pmc logo imageJournal ListSearchpmc logo image
Logo of cvmNow Published as Trials.BioMed Central web siteSearch.Manuscript submission.Registration.Journal front page.
Other Issues:  previous | next | latest | archive
Volume 2(4);  2001
Commentaries
How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
Vernon VS Bonarjee and Kenneth Dickstein
Curr Control Trials Cardiovasc Med. 2001; 2(4): 151–155. Published online 2001 June 26. doi: 10.1186/cvm-2-4-151.
PMCID: PMC59642
Dose response of ACE inhibitors: implications of the SECURE trial
Eva Lonn
Curr Control Trials Cardiovasc Med. 2001; 2(4): 155–159. Published online 2001 July 6. doi: 10.1186/cvm-2-4-155.
PMCID: PMC59639
Organizing the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): National Institutes of Health, Health Care Financing Administration, and industry funding
Robert W Hobson, II, Virginia J Howard, Thomas G Brott, George Howard, Gary S Roubin, Robert DG Ferguson, and for the CREST Executive Committee
Curr Control Trials Cardiovasc Med. 2001; 2(4): 160–164. Published online 2001 July 13. doi: 10.1186/cvm-2-4-160.
PMCID: PMC59640
Reviews
The role of dyslipidemia and statins in venous thromboembolism
Joel G Ray and Frits R Rosendaal
Curr Control Trials Cardiovasc Med. 2001; 2(4): 165–170. Published online 2001 July 20. doi: 10.1186/cvm-2-4-165.
PMCID: PMC59643
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
Jassim Al Suwaidi and Amar M Salam
Curr Control Trials Cardiovasc Med. 2001; 2(4): 171–179. Published online 2001 July 26. doi: 10.1186/cvm-2-4-171.
PMCID: PMC59641
Research
Systematic adjudication of myocardial infarction end-points in an international clinical trial
Kenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, Neal S Kleiman, Lisa G Berdan, Brian S Crenshaw, Barbara E Tardiff, Christopher B Granger, Ingrid DeJong, Manju Bhapkar, Petr Widimsky, Ramón Corbalon, Kerry L Lee, Jaap W Deckers, Maarten L Simoons, Eric J Topol, Robert M Califf, and for the PURSUIT Investigators
Curr Control Trials Cardiovasc Med. 2001; 2(4): 180–186. Published online 2001 July 17. doi: 10.1186/cvm-2-4-180.
PMCID: PMC57749
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study
Kenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, Neal S Kleiman, Lisa G Berdan, Brian S Crenshaw, Barbara E Tardiff, Christopher B Granger, Ingrid DeJong, Manju Bhapkar, Petr Widimsky, Ramón Corbalon, Kerry L Lee, Jaap W Deckers, Maarten L Simoons, Eric J Topol, Robert M Califf, and for the PURSUIT Investigators
Curr Control Trials Cardiovasc Med. 2001; 2(4): 187–194. Published online 2001 July 17. doi: 10.1186/cvm-2-4-187.
PMCID: PMC57750
Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN41194621]
Thomas W Meade and for the British Medical Research Council General Practice Research Framework and participating vascular clinics
Curr Control Trials Cardiovasc Med. 2001; 2(4): 195–204. Published online 2001 July 23. doi: 10.1186/cvm-2-4-195.
PMCID: PMC57751
Other Issues:  previous | next | latest | archive
Articles from Current Controlled Trials in Cardiovascular Medicine are provided here courtesy of
BioMed Central